HeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG ...
GlobalData on MSN
HeartBeam commences pilot study of new 12-lead ECG patch
The study will enrol around 50 high-risk coronary artery disease patients whose resting ECGs show no signs of ischemia.
KELOWNA, BC / / May 5, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in ...
Monday, May 18, at 9 a.m. is the deadline to submit letters of intent (LOIs) for the UB Clinical and Translational Science Institute (CTSI) spring 2026 Translational Pilot Studies Program; see request ...
Monday, May 19, at 9 a.m. is the deadline to submit letters of intent (LOIs) for the UB Clinical and Translational Science Institute (CTSI) spring 2025 Translational Pilot Studies Program; see Request ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results